M-HEALTH By PHARMAGEEK

Some questions for the chat:

1. Is the return on investment (ROI) of mHealth Apps too low or difficult to measure? What are the important key performance indicators (KPI's) today? Which are most useful?
2. How can pharma enhance its expertise for the development of mHealth Apps? Should it be in-house or outsourced? What about incubating and investing in mHealth start-ups? 
3. Is traditional thinking stymying mHealth innovation within pharma? For example, is pharma's traditional "sell the pill" business model incompatible with what the market (physicians and patients) want from mHealth Apps? 
4. Are there pharma companies out there who have solved all these problems and developed, in your opinion, high quality mHealth Apps? Who are they and what are the apps?